Zhejiang CONBA Pharmaceutical Co.,Ltd.

SHSE:600572 Stock Report

Market Cap: CN¥10.7b

Zhejiang CONBA PharmaceuticalLtd Future Growth

Future criteria checks 3/6

Zhejiang CONBA PharmaceuticalLtd is forecast to grow earnings and revenue by 21.9% and 14.8% per annum respectively. EPS is expected to grow by 21.7% per annum. Return on equity is forecast to be 11.3% in 3 years.

Key information

21.9%

Earnings growth rate

21.7%

EPS growth rate

Pharmaceuticals earnings growth18.3%
Revenue growth rate14.8%
Future return on equity11.3%
Analyst coverage

Low

Last updated11 Jun 2024

Recent future growth updates

No updates

Recent updates

Here's Why Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) Can Manage Its Debt Responsibly

May 21
Here's Why Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) Can Manage Its Debt Responsibly

Earnings and Revenue Growth Forecasts

SHSE:600572 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20269,6621,009N/A1,3322
12/31/20258,729884N/A1,3273
12/31/20247,533752N/A9951
3/31/20246,426523750977N/A
12/31/20236,733592689899N/A
9/30/20236,6967521,0201,295N/A
6/30/20236,6846629651,242N/A
3/31/20236,4305398931,186N/A
12/31/20226,0003588641,155N/A
9/30/20226,1412,027453856N/A
6/30/20226,5301,984355846N/A
3/31/20226,6782,073251782N/A
12/31/20216,5682,017310891N/A
9/30/20216,2821296731,150N/A
6/30/20215,8342157831,232N/A
3/31/20215,8213196451,128N/A
12/31/20205,9094537891,250N/A
9/30/20205,918-276414838N/A
6/30/20206,313-252572925N/A
3/31/20206,707-3427331,018N/A
12/31/20196,768-346657926N/A
9/30/20196,855515723971N/A
6/30/20196,978652365710N/A
3/31/20196,975726238606N/A
12/31/20187,018815161549N/A
9/30/20187,067879107531N/A
6/30/20186,644880311633N/A
3/31/20185,979790370656N/A
12/31/20175,294711N/A714N/A
9/30/20175,266598N/A784N/A
6/30/20175,311519N/A839N/A
3/31/20175,640477N/A925N/A
12/31/20166,020441N/A970N/A
9/30/20166,092275N/A1,178N/A
6/30/20166,141308N/A1,077N/A
3/31/20165,882468N/A960N/A
12/31/20155,302440N/A831N/A
9/30/20154,758770N/A548N/A
6/30/20154,114704N/A562N/A
3/31/20153,746539N/A666N/A
12/31/20143,582552N/A617N/A
9/30/20143,398509N/A478N/A
6/30/20143,212499N/A325N/A
3/31/20142,985451N/A176N/A
12/31/20132,924417N/A235N/A
9/30/20132,824407N/A301N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600572's forecast earnings growth (21.9% per year) is above the savings rate (2.9%).

Earnings vs Market: 600572's earnings (21.9% per year) are forecast to grow slower than the CN market (22.2% per year).

High Growth Earnings: 600572's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600572's revenue (14.8% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 600572's revenue (14.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 600572's Return on Equity is forecast to be low in 3 years time (11.3%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.